← Open Payments lookup

JOSEPH SHEMWELL: Open Payments

NPI 1710505391 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,813 in 110 payments from 21 companies in 2025. Trend: 2023 $1,479 · 2024 $2,100 · 2025 $1,813

Food & beverage: $1,813
CompanyPaymentsAmount
ABBVIE INC.45$585
Janssen Biotech, Inc.9$165
Ardelyx, Inc.6$154
Madrigal Pharmaceuticals5$148
Takeda Pharmaceuticals U.S.A., Inc.8$140
Lilly USA, LLC6$98
Aimmune Therapeutics, Inc.4$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$74
Phathom Pharmaceuticals, Inc.5$52
Ipsen Biopharmaceuticals, Inc3$51

Products named: RINVOQ, TREMFYA, IBSRELA, REZDIFFRA, ENTYVIO, SKYRIZI, OMVOH, LINZESS.

Industry payments across MS — which companies pay providers there.